Last updated on December 11, 2019
Healthcare providers and health systems all around the world are shifting. As an essential part of the health programs, pharmacists, physicians, nurses and other health care professionals will need to accommodate and proceed to satisfy the requirements of the patients and authorities.
Although modern medical therapies are saving lives, a rise in the deficiency of curative adherence in patients – particularly the ones that are polymedicated – is seen throughout the continent.
The amounts are all clear on this issue. At a social level, these startling figures have deleterious effects, using an estimated 200,000 premature deaths each year in Europe coming from drug non-adherence. Of these, roughly 18,000 are enrolled in Spain alone. The dearth of drug adherence also comes at a huge price for EU member countries, making $125 billion in surplus healthcare costs.
Pharmacies and health care professionals are well conscious of those inefficiencies and have designed, developed and established the Personalised Dose System (PDS), which divides medicinal products into components that include the personalized components of medication an individual patient should consider at a specific time and day. This program helps patients with carrying their medication correctly and punctually, particularly those polymedicated patients that frequently struggle to follow their remedies rigorously.
Community pharmacists can also be relying upon dosage dispensing to reduce discrepancies between patient medication records and healthcare providers, offer advice for patients’ adherence, and encourage disease prevention and wellness education.
Though the personalized dose process isn’t needed for the majority of patients, its debut for specific groups ought to be required. Back in Spain, the context of an aging society and rising instances of drug errors necessitates the urgent execution of a dose dispensing system. As much as 80 percent of the entire healthcare cost of Spain is dedicated to chronic patients, half of whom don’t adhere to their drugs. Additionally, three out of 10 patients quit taking their drugs after beginning treatment, and nearly half of chronic patients self-regulate their medicine.
Although laws to foster the execution of dose dispensing are nonexistent at a federal level, a few regional governments in Spain back this medical option.
We at SEFAC consider that lots of the issues faced by particular patient groups – chronic, determined, polymedicated – in there, every day lives might be alleviated or resolved if pharmacists were empowered and dose dispensing was set in place throughout the nation, not at a neighborhood level.
Though dose dispensing isn’t yet a frequent practice during the EU, it’s shown beneficial where it’s been utilized, improving the standard of life of individuals, leading to decreased time specializing in prescribing and administering medication (GPs and community pharmacists), finally strengthening better drug compliance in patients along with a cost-effective clinical effects.
All health care providers discuss the mission of ensuring a secure, accountable, effective and efficient utilization of services, health care interventions and medications, with the ultimate aim of optimizing health effects. It’s particularly worrying that there’s not any legal framework to encourage dose dispensing in several EU states as a powerful tool to increase drug safety, along with the pharmaceutical follow-up, which might be articulated by reimbursing the pharmacists for its support.